{"basic_info": {"ticker": "600161", "exchange": "XSHG", "bloomberg_ticker": "600161 CH Equity", "name": "BEIJING TIANTAN BIOLOGICAL-A", "industry": "Biotechnology", "name_chinese_simplified": "天坛生物", "period": "2020", "market_value": 52598677504, "total_income": 1554808380, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 1549601241, "business_income_over_total_income": 0.9966509448579123}, {"shariah_compliance": "unknown", "income": 5207139, "business_income_over_total_income": 0.00334905514208767}], "details": [{"business_activity_cn": "血液制品", "business_activity_en": "Blood products", "income": 1549601241, "business_income_over_total_income": 0.9966509448579123, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他", "business_activity_en": "other", "income": 5207139, "business_income_over_total_income": 0.00334905514208767, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.018949363988709392, "shariah_compliance": "compliant", "amount_over_market_value": 0.018949363988709392}]}